Annual subscription of Chemical Abstracts Service (CAS) BioFinder Discovery Platform Software Licenseview on SAM.gov

Pre-Solicitation Notice – Notice of Intent to award on a Single Source Basis Title: Notice of Intent to Award a Single Source Purchase Order for an annual subscription of a Chemical Abstracts Service (CAS) BioFinder Discovery Platform Software License, a computational platform that can predict thousands of biological targets for chemicals, is accessed via the Internet, and interfaces with CAS SciFinder, a database of over 100 million chemicals and already in use by the FDA. Notice Number: NOI_REQT-OMAS-IT-202600119 Agency: Department of Health and Human Services (HHS), Food and Drug Administration (FDA) Division of Toxicology Contracting Office: HHS – Office of Mission Acquisition Solutions Product Service Code (PSC): OC code 6632 / PCS Code 10 (Analysis Instruments, Medical Laboratory Use) NAICS Code: 513210 (Software Publishers) Place of Performance: HHS/FDA, 8301 Muirkirk Road, Laurel, MD 20708 Set Aside: Not Applicable (Single Source) Response Date: 07/15/2026 5:00 PM MST Description This is a Notice of Intent to negotiate on a sole source basis for a firm-fixed-price purchase order to American Chemical Society, 2540 Olentangy River Road, Columbus, OH 43202 HHS/FDA has a requirement for purchase of an annual software license. The Chemical Abstracts Service (CAS) BioFinder Discovery Platform is the only platform that meets all of the FDA Division of Toxicology's technical requirements for advancing food chemical safety research and implementing New Approach Methodologies (NAMs). Period of Performance: 09/01/2026 – 08/31/2027 Requirement Details: Prediction of biological targets for chemicals based on a training set of over 1 million compounds Known and predicted quantitative binding and functional activity for at least 3,600 targets Target binding prediction by at least 6 independent methods (SAS, SAR, SIM, SEA, MLM, and XPI) Confidence scores for predicted interactions using consensus approach Metabolite prediction using manually curated training dataset Direct comparison of biological target predictions of metabolites with substrates Interactive tabular and graphical dashboards for data visualization Integration with CAS SciFinder database containing over 100 million substances – already being utilized by FDA Web browser access with user account credentials Downloadable search results in structured data format AI chatbot interface (CAS Newton) for data queries Matched molecular pair analysis capabilities Justification for Sole Source: The highly specialized nature of this requirement, including the unique combination of comprehensive curated data, multiple independent prediction algorithms, extensive biological target coverage, metabolite prediction, CAS SciFinder integration, and full literature traceability, significantly limits the supplier pool to CAS as the sole source capable of meeting FDA's needs. Proprietary Technology: The Chemical Abstracts Service (CAS) BioFinder Discovery Platform is the only platform that meets all of th…